1. Generics Bulletin
  3. >>Deals

Perrigo Bolsters US Generics Ahead Of Separation Plans

Signed Eighth Agreement With Sol-Gel To Further Expand Partnership

 
• By Dean Rudge

Perrigo has expanded its agreement with Sol-Gel Technologies to cover ten products, shortly after warning that plans to separate the firm’s Prescription Pharmaceuticals US generics unit “in the short term” would likely “destroy shareholder value.”

Blocks
Perrigo and dermatology specialist Sol-Gel have once again added to their collaboration • Source: Shutterstock

Perrigo has expanded its development, manufacturing and commercialization agreement with dermatology specialist Sol-Gel Technologies by adding three new generic product candidates, ahead of continued plans to separate Perrigo’s US generics Prescription Pharmaceuticals business.

With the latest agreement, the eighth in total, Perrigo and Sol-Gel’s collaboration now covers ten products

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business

Apotex Extends Formosa Ophthalmic Alliance Into Mexico

 
• By Dave Wallace

Apotex has expanded an alliance formed with Formosa in August for its novel clobetasol propionate ophthalmic treatment, adding Mexican rights to its existing deal for the Canadian market.

Fresenius Kabi Lauds Tocilizumab Momentum As ‘Intense’ Transfer To mAbxience Continues

 
• By Dean Rudge

Fresenius Kabi continued to reap the rewards of its fledgling commercial Biopharma business in the first quarter, as the firm eyes further growth for its tocilizumab biosimilar in the US and Europe in the second half of 2025.

US FDA Expands Surprise Foreign Inspections

 
• By Sue Sutter

Commissioner Martin Makary’s repeated characterization of foreign facilities as being subject to lower standards than domestic counterparts may have contributed to Rogers’ decision to retire as head of the recently formed Office of Inspections and Investigations.